相关实验视频

Updated: Jun 10, 2025

Author Spotlight: Advancements in DNA Nanosensors – Addressing Sensitivity and Selectivity Challenges in Molecular Detection

Author Spotlight: Advancements in DNA Nanosensors – Addressing Sensitivity and Selectivity Challenges in Molecular Detection

Published on: February 9, 2024

自适应激活DNA酶纳米组件用于协同组合基因疗法

Jing Wang^1,2, Jinhua Shang¹, Shanshan Yu¹

¹College of Chemistry and Molecular Sciences, Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan University, 430072, Wuhan, P. R. China.

Angewandte Chemie (International ed. in English)

|October 17, 2024

概括

这项研究介绍了一种新的DNA纳米组件,用于使用DNAzyme技术进行向基因沉默. 纳米组件有效地提供治疗剂,克服了传递挑战,提高了癌症治疗效率.

科学领域:

生物化学生物化学
分子生物学分子生物学
纳米技术纳米技术

背景情况:

DNA酶提供了基因沉默潜力,但在细胞传递和基质可访问性方面面临挑战.
针对治疗剂的向输送对于在特定细胞类型中有效的基因沉默至关重要.
瘤转移和化疗耐药性是癌症治疗中的重大障碍,通常与特定的信号通路有关.

研究的目的:

开发一个紧的DNA纳米组件,用于选择性地输送治疗性DNA酶和辅助因子.
设计一种自我适应的负反循环,用于持续的基因沉默和治疗剂激活.
通过准TWIST/miR-10b信号节点来废除瘤转移和化疗耐药性.

主要方法:

准备一个多重的治疗DNA酶结合的DNA纳米组件.
使用序列保护双重特异核酶用于miRNA催化DNA纳米组装基质的裂变.
设计一个miR-10b刺激的DNA酶来降低TWIST转录因子的调节.

主要成果:

该DNA纳米组件实现了对基因沉默DNAzymes和化疗药物的选择性传递.
纳米组装基质的内源miRNA介导裂变确保了治疗剂的准确和有效释放.
建立了一个自我适应的负反循环,导致TWIST/miR-10b信号的自给自足下调.

结论:

开发的DNA纳米组件有效地克服了基于DNA酶的基因沉默的基底可访问性问题.
针对TWIST/miR-10b信号节点的定向下调显示出在废除瘤转移和化疗耐药性方面具有前景.
这种方法通过整合基因沉默,向传递和反调节,为癌症治疗提供了一种新的策略.

关键词:

这是一个DNA机器,一个DNA机器.这就是DNAzyme DNA酶.基因沉默是对基因进行沉默的方法.影像成像技术影像成像技术这是一个微型RNA.

更多相关视频

Combining QD-FRET and Microfluidics to Monitor DNA Nanocomplex Self-Assembly in Real-Time

Combining QD-FRET and Microfluidics to Monitor DNA Nanocomplex Self-Assembly in Real-Time

Published on: August 26, 2009

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...